Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 12, 2021

SELL
$26.38 - $51.15 $1.02 Million - $1.97 Million
-38,600 Closed
0 $0
Q4 2020

Jan 19, 2021

BUY
$10.5 - $28.5 $405,300 - $1.1 Million
38,600 New
38,600 $1 Million
Q1 2020

Apr 09, 2020

SELL
$2.36 - $5.26 $9,286 - $20,698
-3,935 Closed
0 $0
Q4 2019

Jan 10, 2020

BUY
$4.6 - $5.57 $459 - $557
100 Added 2.61%
3,935 $20,000
Q3 2019

Oct 25, 2019

SELL
$4.99 - $6.16 $36,751 - $45,368
-7,365 Reduced 65.76%
3,835 $19,000
Q2 2019

Jul 24, 2019

BUY
$5.92 - $7.41 $44,992 - $56,316
7,600 Added 211.11%
11,200 $67,000
Q1 2019

Apr 17, 2019

BUY
$6.8 - $7.4 $27 - $29
4 Added 0.11%
3,600 $26,000
Q4 2018

Jan 22, 2019

BUY
$3.99 - $7.82 $14,348 - $28,120
3,596 New
3,596 $26,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $416M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.